We work with innovators of biotech, healthcare, science, sustainability, and advanced technology
Case study: transforming the narrative on PVC production
ZingPR helped Transform Materials, a Florida-based deeptech startup, announce a groundbreaking collaboration with Johnson Matthey that's set to revolutionize the PVC industry. Our strategic media outreach focused on highlighting the partnership's environmental benefits, scalability, and industry-leading expertise.
How to… make your science news stand out
In the world of science PR, it's not enough to have groundbreaking research – you need a story that grips. A narrative that not only informs but also intrigues. So how do you break through the clutter and make your science news sing?
High-tech PR win: inside OSARO's robotic depalletization system launch campaign
Launching a new robotics solution is always a challenge. It's highly technical and can be difficult to translate for a general audience. That's why OSARO partnered with ZingPR to craft a compelling media strategy. Instead of focusing on specs, we highlighted the real-world benefits: warehouse safety and efficiency.
rBIO biosimilar insulin advances to clinical trials — strategy by ZingPR
rBIO's biosimilar insulin story landed in Wired, MedCity News, and more. See the PR tactics that drove success and get tips for your biotech launch.
CureLab's DNA vaccine prolongs the life of platinum-resistant ovarian cancer patients
CureLab Oncology’s DNA vaccine Elenagen, in combination with a proven chemotherapy, demonstrates promising clinical results against one of the deadliest forms of ovarian cancer.
Gero is applying AI to crack the code of complex diseases and aging
Gero is a cutting-edge biotechnology company dedicated to the mission of curing age-related human diseases and understanding, slowing, and even halting the aging process itself.
Cyclica teams with Bill & Melinda Gates Foundation for non-hormonal contraceptives
Cyclica will apply its AI-enabled drug discovery platform to discover new therapeutic options with the goal of expanding the range of accessible non-hormonal contraceptive choices for women in developing countries.
GenScript and Avectas aim to reduce the cost of non-viral cell engineering
Two biotech leaders have embarked on a research project to streamline manufacturing of non-viral CRISPR gene editing components. Their goal is to improve the editing efficiency and cell viability of non-viral-based cell therapies.
CureLab Oncology's cancer therapy shows progress in clinical study
The clinical benefits currently delivered for terminally ill patients in CureLab’s clinical trial are already exceeding the benefits of new drugs recently approved by the FDA.
Luma Health debuts LumaPay — now patients can pay med bills via SMS
LumaPay™ enables patients to pay their bills right from text messages or their providers' websites. The announcement is part of a broader repositioning of Luma's focus on patient success.
GenScript enables new workflows for CRISPR HDR cell therapy development
GenScript’s new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services enable new workflows
Allelica and Invitae team to better identify women at risk for breast cancer
Allelica and Invitae want to integrate lifesaving genomic information into breast cancer risk assessments — for the benefit all women
Opalia’s animal-free milk is now one step closer to supermarket shelves
Opalia hits a key go-to-market milestone by eliminating fetal bovine serum from its cell-based milk manufacturing process
Polygenic risk score company Allelica adds US scientists to advisory board
Allelica, the leader in Polygenic Risk Scoring, expands scientific advisory board
OSARO partners with INNOTECH to build picking robots for Rohto Pharma
INNOTECH and OSARO collaborate to build a demonstration AI-powered picking-robot system for Rohto Pharmaceutical’s next-generation smart factory
Transform Materials' onsite hydrogen production tech selected for Hyzon Motors back-to-base applications
Hyzon Motors to collaborate with Transform Materials on renewable hydrogen production for ‘back to base’ hydrogen-powered trucks.